Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
GoldQuest Closes Second Tranche of Private Placement
-
Minera IRL Limited: Response to False Media Speculation
-
Canaccord Genuity Downgrades EnerNOC (ENOC) to Hold
-
Canaccord Genuity Upgrades BCE (BCE) to Buy
-
Canaccord Genuity Downgrades Glu Mobile (GLUU) to Hold
-
Canaccord Genuity Starts Energy Focus (EFOI) at Buy
-
Penumbra, Inc. to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
-
Vascular Solutions to Present at the Canaccord Genuity Medical Technology and Diagnostics Forum
-
NanoString Technologies to Present at Canaccord Genuity Medical Technology and Diagnostics Forum
-
NanoString Technologies to Present at Canaccord Genuity Medical Technology and Diagnostics Forum
-
HTG Molecular Diagnostics to Present at the Canaccord Genuity Medical Technologies and Diagnostics Forum
-
Nighthawk Energy plc ("Nighthawk" or "the Company") Borrowing Base Redetermination and Production Hedging Update
-
Facebook (FB) PT Raised to $135 at Canaccord Genuity
-
Boston Scientific To Participate In Canaccord Genuity 2015 Medical Technology And Diagnostics Forum
-
Canaccord Genuity Group Inc. reports second quarter fiscal 2016 results
-
Spectranetics to Participate in Upcoming Investor Conferences
-
The Manufacturer of the SynCardia Total Artificial Heart has Hired Investment Bank Canaccord Genuity, Inc. to Advise the BOD on Strategic Alternatives to Maximize Stakeholder Equity
-
LeMaitre Vascular to Present at Four Investor Conferences in November
-
MDxHealth to Present at November 2015 Investor Conferences
-
TearLab to Participate in November Investor Conferences
-
TearLab to Participate in November Investor Conferences
-
Exact Sciences to Participate in November Investor Conferences
-
Canaccord Genuity Downgrades Enphase Energy (ENPH) to Hold
-
MDxHealth to Present at November 2015 Investor Conferences
-
Veresen Announces 2015 Third Quarter Results and Updates Guidance
-
Avinger, Inc. to Present at Upcoming Investor Conferences
-
Essex Property Trust (ESS) Continues to Benefit From Driven Job Growth; Canaccord Genuity Reiterates Hold
-
Canaccord Genuity Cuts Price Target on Michael Kors (KORS) Ahead of 2Q16 Results
-
Demandware's (DWRE) GMV Commentary Creates More Questions Than Answers; Canaccord Genuity Cuts Price Target to $68
-
Canaccord Genuity Cuts Price Target on Cognex Corp (CGNX) Following In-Line 3Q Results
-
Canaccord Genuity Raises Price Target on CEVA, Inc. (CEVA) Following 3Q
-
Genomic Health to Present at Two Upcoming Investor Conferences
-
Canaccord Genuity Downgrades Constant Contact (CTCT) to Hold
-
Intersect ENT to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
-
Goldman Sachs says Valeant has long road ahead, cuts rating
-
American Tower (AMT) International Expansion and Global Data Growth Drive AMT to Outperform - Cannacord Genuity
-
Canaccord Genuity Reiterates Hold Rating on SodaStream (SODA) Ahead of 3Q
-
Canaccord Genuity Cuts Price Target on Keurig Green Mountain (GMCR) Ahead of 4Q
-
TransEnterix, Inc. to Present at Two Upcoming Investor Conferences
-
NOVADAQ to Participate in November Investor Events
-
Atalaya Mining PLC Announces Receipt of Claim From Astor Management AG
-
UPDATE: Canaccord Genuity Upgrades BE Aerospace (BEAV) to Buy
-
Canaccord Genuity Downgrades RTI Biologics (RTIX) to Hold
-
PayPal (PYPL) Reaffirms Guidance Following Solid 3Q; Canaccord Genuity Reiterates Buy
-
InvenSense (INVN) Reports Slight 2Q EPS Beat; Canaccord Genuity Reiterates Buy
-
Each Segment Down Q/Q as Atmel Corp (ATML) Guided; Canaccord Genuity Cuts Price Target to $8.85
-
Equinix (EQIX) Reports Record Cross Connects; Canaccord Genuity Raises Price Target to $320
-
LifeLock (LOCK) PT Lifted to $17 at Canaccord Genuity as FTC 'Deathblow' Now Off the Table
-
BTV Showcases Mag One Products and reLiSH Gourmet Burgers
-
GenMark Diagnostics (GNMK) Announces Another ePlex Delay; Canaccord Genuity Cuts Price Target to $8

